One Health Movement News / One Health Topics 'in' the News

HAMBURG: The G20 nations, including India, today pledged to strengthen health systems and also combat the menace of antimicrobial resistance, which the grouping termed as a "growing threat" to public health and economic growth.  The declaration adopted by the nations said they would aim to tackle the spread of AMR through the implementation of their respective national action plans based on "one health" approach. View the G-20 Leaders' Declaration HERE (see bottom of page 8). 

Fifteen stakeholders from the AAVMC, the Association of Public and Land-Grant Universities (APLU), the Food & Agriculture Organization of the United Nations (FAO), and the World Bank met at the FAO Liaison Office for North America in Washington, D.C. in early April to discuss strategies for mitigating the antimicrobial resistance (AMR) problem. Talks focused on educational, research and policy development initiatives with international impact, including methods for educating stakeholders, the potential establishment of a university-based Center of Excellence to coordinate research and educational programs, and Congressional outreach and potential One Health legislation.

One Health at Iowa State presents Physicians, Farmers, and the Politics of Antimicrobial Resistance by Laura H. Kahn, MD, MPH, MPP in honor of Dr. Roger Mahr, former CEO of the One Health Commission

March 21, 2017, at 5:30 pm (Central).  

Click link to recorded session

On 21 September 2016, the President of the UN General Assembly convenes an one-day high-level meeting at the UN Headquarters in New York on “Antimicrobial Resistance“, with the participation of Member States, non-governmental organizations, civil society, the private sector and academic institutions, in order to provide input.

The primary objective of the meeting is to summon and maintain strong national, regional and international political commitment in addressing antimicrobial resistance comprehensively and multi-sectorally, and to increase and improve awareness of antimicrobial resistance.

"At the 84th General Session of the World Assembly of National Delegates, the OIE presented to its Members, and proposed for adoption, the basic principles of its new strategy to fight antimicrobial resistance. Built on the foundations of many years’ work by the Organisation to protect the effectiveness of antimicrobials used in veterinary medicine, and to contribute towards maintaining the efficacy of the molecules used in human medicine, this strategy aims to provide countries with the necessary tools to assist them in managing this problem more effectively, regardless of their actual animal health situation. "

Excerpt: "In mid-November, a group of Chinese and UK researchers published a paper in The Lancet delivering some sobering news: They had found a strain of E. coli in Chinese pigs that had evolved to withstand colistin, a potent antibiotic widely considered to be a last resort against a variety of pathogens that can resist antibiotics. Worse, the gene that allowed the E. coli to shrug off colistin easily jumps among bacterial species, and is thus "likely to spread rapidly into key human pathogens"—think fun stuff like salmonella and Klebsiella. The cherry on top: The authors warn that these colistin-defying nasties are "likely" to go global."

Excerpt: "The President has proclaimed Nov. 16-22 “Get Smart About Antibiotics Week.”    Get Smart Week builds on the momentum generated at the White House Forum on Antibiotic Stewardship, where more than 150 organizations pledged to improve antibiotic use and slow the spread of antibiotic resistance.

Antibiotic resistance – the rise of deadly germs no longer stopped by the drugs that once controlled them – threatens to take us back to the days when minor infections commonly killed.

CDC estimates that each year two million Americans get an infection with an antibiotic-resistant bacteria. Every year 23,000 of those patients die. CDC has made combating antibiotic resistance a top priority and is partnering with public institutions and private industry to overcome this challenge. It is critical to use these life-saving drugs when truly necessary, such as when treating patients with sepsis, while also using the right drug at the right dose and duration to  protect the effectiveness of antibiotics."

"Today the Infectious Diseases Society of America (IDSA) launched the U.S. Stakeholder Forum on Antimicrobial Resistance (S-FAR) and released the Forum’s foundational principles. More than 75 national organizations, representing medical and allied health professionals, hospitals and other healthcare facilities, patients and consumers, public health, research and advocacy, industry, and international health organizations have joined the partnership so far. Partners will convene for the inaugural S-FAR meeting in Philadelphia on Oct. 9, 2014."